Utility of Recombinant Envelope Domain III as a Diagnostic Antigen for the Specific Detection of Kyasanur Forest Disease
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.70820 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Sayad Hafeez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of PG Studies and Research in Microbiology, Kuvempu University, Jnana Sahyadri, Shankaraghatta, Karnataka, India. Hauptthemen laut MEDLINE: Kyasanur Forest Disease, Antigens, Viral, Encephalitis Viruses, Tick-Borne, Viral Envelope Proteins. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Vision Group on Science and Technology, Lady Tata Memorial Trust.
Abstract (Originalsprache)
Kyasanur Forest Disease (KFD), commonly known as ‘monkey fever,’ is a highly neglected tropical disease caused by the Kyasanur Forest Disease Virus (KFDV). KFD is endemic to the Western Ghats of Karnataka, India, with seasonal outbreaks during December to June every year. As there is no standard treatment regime, KFD can be fatal with a mortality rate of 2%–10%. Currently, KFD is detected through a non‐specific IgM‐ELISA followed by RT‐PCR, which often delays diagnosis, leading to increased disease severity and even death. To address this, we focused on developing a specific antigen‐based KFD detection. The KFDV Envelope Domain III (EDIII) and Non‐Structural 1 (NS1) proteins were chosen as detection markers, cloned, and expressed using pET28a(+) vector in BL‐21 (Rosetta) E. coli and purified. These proteins were used to raise polyclonal antibodies in rabbits and the antibody titre was found to be 1:256 000 and 1:512 000 against rEDIII and rNS1 proteins, respectively. Importantly, these polyclonal antibodies showed no cross‐reactivity against corresponding dengue virus EDIII and NS1 proteins. Using polyclonal antibodies against rEDIII, we developed sandwich ELISA for the specific detection of KFD, which has demonstrated high specificity and sensitivity. Further, anti‐rEDIII polyclonal antibodies also detected full‐length KFDV‐E protein expressed in mammalian cells, confirming the antibody specificity for the native viral antigen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of PG Studies and Research in Microbiology, Kuvempu University, Jnana Sahyadri, Shankaraghatta, Karnataka, India.
- Department of PG Studies and Research in Biochemistry, Kuvempu University, Jnana Sahyadri, Shankaraghatta, Karnataka, India.
- Molecular Bioassay Laboratory, Institute of Advanced Virology (IAV), Thiruvananthapuram, Kerala, India.
- School of Life Sciences, JSS Academy of Higher Education and Research (AHER), Mysuru, Karnataka, India.
- Department of Biochemistry, Srinivas Institute of Medical Science and Research Centre, Srinivas University, Mangaluru, D. K, Karnataka, India.
ORCID-Profile: Sayad Hafeez, Rajeshwara Achur, Vivek Vijay, Easwaran Sreekumar, Asha Srinivasan, Suchetha Kumari, N B Thippeswamy
Förderung
- Vision Group on Science and Technology
- Lady Tata Memorial Trust
Zitieren
APA
Hafeez, S., Achur, R., Vijay, V., Sreekumar, E., Srinivasan, A., Kumari, S., & Thippeswamy, N. B. (2026). Utility of Recombinant Envelope Domain III as a Diagnostic Antigen for the Specific Detection of Kyasanur Forest Disease. Journal of Medical Virology. https://doi.org/10.1002/jmv.70820
Vancouver
Hafeez S, Achur R, Vijay V, Sreekumar E, Srinivasan A, Kumari S, et al. Utility of Recombinant Envelope Domain III as a Diagnostic Antigen for the Specific Detection of Kyasanur Forest Disease. Journal of Medical Virology. 2026. doi:10.1002/jmv.70820
BibTeX
@article{Hafeez2026,
author = {Hafeez, Sayad and Achur, Rajeshwara and Vijay, Vivek and Sreekumar, Easwaran and Srinivasan, Asha and Kumari, Suchetha and Thippeswamy, N B},
title = {Utility of Recombinant Envelope Domain III as a Diagnostic Antigen for the Specific Detection of Kyasanur Forest Disease},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.70820}
}
EUVIMED